迪尔生物 (873831.OC)

+ 收藏

利润表(迪尔生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 96,918,086.91206,701,380.3796,293,909.61161,643,103.8171,843,953.02
 营业收入(元) 96,918,086.91206,701,380.3796,293,909.61161,643,103.8171,843,953.02
二、营业总成本(元) 77,634,194.86166,411,283.9277,084,030.44138,603,108.7461,445,072.58
 营业成本(元) 43,495,256.6393,991,837.3643,402,469.5073,785,113.4031,695,132.01
 研发费用(元) 10,339,473.3420,860,770.389,637,749.6022,229,023.4410,266,937.78
 营业税金及附加(元) 894,638.681,922,608.98479,674.251,235,887.95243,693.27
 销售费用(元) 14,470,964.0333,156,906.0015,910,822.3624,748,641.7711,287,715.74
 管理费用(元) 9,852,729.3118,351,494.389,446,932.0418,605,485.338,907,665.31
 财务费用(元) -1,418,867.13-1,872,333.18-1,793,617.31-2,001,043.15-956,071.53
  其中:利息收入(元) 1,066,499.721,486,239.66-399,979.91--76,217.52
三、其他经营收益
 加:公允价值变动收益(元) 124,808.40534,190.55255,448.36388,846.77156,417.85
 加:投资收益(元) 437,544.88916,047.49516,090.301,110,449.29811,271.22
 资产减值损失(元) -141,934.43-824,355.31-17,197.34-240,520.22-92,123.55
 信用减值损失(元) -18,472.49-129,009.25109,887.84-102,935.3090,152.71
 其他收益(元) 1,348,817.53442,775.8834,514.04470,706.70-
四、营业利润(元) 21,034,655.9441,229,745.8120,108,622.3724,666,542.3111,364,598.67
 加:营业外收入(元) -4,553.814,550.0160,206.0316,050.00
 减:营业外支出(元) 10,215.5821,422.1410,000.00180,214.0110,062.69
五、利润总额(元) 21,024,440.3641,212,877.4820,103,172.3824,546,534.3311,370,585.98
 减:所得税费用(元) 1,822,949.633,868,447.291,993,441.451,359,916.27457,233.54
六、净利润(元) 19,201,490.7337,344,430.1918,109,730.9323,186,618.0610,913,352.44
(一)按经营持续性分类
  持续经营净利润(元) 19,201,490.7337,344,430.1918,109,730.9323,186,618.0610,913,352.44
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 19,532,544.1137,989,902.4418,435,079.6423,796,372.0811,212,341.53
  少数股东损益(元) -331,053.38-645,472.25-325,348.71-609,754.02-298,989.09
 扣除非经常性损益后的净利润(元) 17,898,010.9036,486,653.9217,716,250.0822,165,549.50-
七、每股收益
 一、基本每股收益(元) 0.651.400.750.990.47
 二、稀释每股收益(元) 0.651.400.750.990.47
八、其他综合收益(元) 55,870.3993,649.99164,153.64695,354.26402,347.20
 归属于母公司股东的其他综合收益(元) 93,321.29137,881.60164,153.64930,622.19402,347.20
 归属于少数股东的其他综合收益(元) -37,450.90-44,231.61--235,267.93-
九、综合收益总额(元) 19,257,361.1237,438,080.1818,273,884.5723,881,972.3211,315,699.64
 归属于母公司所有者的综合收益总额(元) 19,625,865.4038,127,784.0418,599,233.2824,726,994.2711,614,688.73
 归属于少数股东的综合收益总额(元) -368,504.28-689,703.86-325,348.71-845,021.95-298,989.09
公告日期 2024-08-282024-04-262023-08-252023-04-142023-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院